Chronic Myelomonocytic Leukemia Terminated Phase 1 Trials for Clofarabine (DB00631)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00852709Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute LeukemiasTreatment
NCT01169012PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute LeukemiasBasic Science